A new study confirms the Harvard University research on the rare eye condition NAION, which affects diabetes patients who use Ozempic. The Danish and Norwegian study found that patients taking Ozempic were more than twice as likely to be diagnosed with NAION compared to those taking another type of diabetes medication. This increased risk remains low, but healthcare providers advise patients to be aware of the potential side effect.
Source: https://www.bloomberg.com/news/articles/2024-12-13/ozempic-link-to-rare-vision-loss-risk-confirmed-in-large-trial